The role of nuclear medicine in infection and inflammation

Lancet Infectious Diseases

Volumn 1, Issue 5, 2001, Pages 326-333

  Becker, W ^a   Meller, J ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

8 QUINOLINOL; 8 QUINOLINOL INDIUM; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FLUORINE; GALLIUM; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; INDIUM; ORGANOMETALLIC COMPOUND; RADIOPHARMACEUTICAL AGENT;

HUMAN; INFECTION; INFLAMMATION; LEUKOCYTE; METHODOLOGY; NUCLEAR MEDICINE; PYREXIA IDIOPATHICA; RADIOIMMUNOASSAY; REVIEW; SCINTISCANNING;

FEVER OF UNKNOWN ORIGIN; FLUORINE RADIOISOTOPES; GALLIUM RADIOISOTOPES; HUMANS; INDIUM RADIOISOTOPES; INFECTION; INFLAMMATION; LEUKOCYTES; NUCLEAR MEDICINE; ORGANOMETALLIC COMPOUNDS; OXYQUINOLINE; RADIOIMMUNODETECTION; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M EXAMETAZIME;

EID: 0035752726     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(01)00146-3     Document Type: Review

References (68)

1. Radiation dose to the patients from radiopharmaceuticals. Recommendations of the International Commission on Radiological Protection. Oxford: Pergamon Press, 1991.
2. Saptogino A., Becker W., Wolf F. Biokinetics and estimation of dose from Tc-99m-labelled polyclonal human immunoglobulin (HIG). Nucl Med. 30:1991;18-23.
3. Buijs W.C.A.M., Oyen W.J.G., Cleaessens R.A.M.J., Koenders E.B., Meeuwis A.P.W., Corsens F.H.M. Biodistribution and radiation dosimetry of indium-111 labelled immunoglobulin G. Eur J Nucl Med. 16:1991;433.
4. Joseph K., Höffken H., Bosslet K., Schorlemmer H.U. In-vivo labelling of granulocytes with Tc-99, anti-NCA monoclonal antibodies from imaging inflammation. Eur J Nucl Med. 14:1988;367-373.
5. Becker W. The contribution of nuclear medicine to the patient with infection. Eur J Nucl Med. 22:1995;1195-1211.
6. Hoffer P. Gallium: mechanisms. J Nucl Med. 21:1980;282-285.
7. Thakur M.L., Lavender J.P., Arnot R.N., Silvester D.J., Segal A.W. Indium-111-labeled autologous leukocytes in man. J Nucl Med. 18:1977;1012-1021.
8. Golden D.W., Cline M.J. Production, distribution and fate of granulocytes. Williams W.J., Beutler E., Erslev A.J., et al. Hematology. 2nd edn :1977;699-706 McGraw Hill, New York.
9. Spector W.G., Lykke W.J., Willoubhgy P.A. A quantitative study of leukocyte emigration in chronic inflammatory granulomata. J Pathol Bacteriol. 93:1967;101-107.
10. Saverymuttu S.H., Camillieri M., Rees H., Lavender J.P., Hodgson H.J.F., Chadwick V.S. Indium-111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. A comparison with colonoscopy, histology and fecal indium-111 granulocyte excretion. Gastroenterology. 90:1986;1121-1128.
11. Becker W., Fischbach H., Jenett M., Reiners C., Börner W. In-111-oxine labelled white cells in the diagnosis and follow-up of Crohn's disease. Klin Wochenschr. 64:1986;141-148.
12. Fischbach W., Becker W. Clinical relevance of activity parameters in Crohn's disease estimated by fecal excretion of In-111-labeled granulocytes. Digestion. 50:1991;149-152.
13. Becker W., Fischbach W., Weppler M., Mösl B., Jocoby G., Börner W. Radiolabeled granulocytes in inflammatory bowel disease: diagnostic possibilities and clinical indications. Nucl Med Commun. 9:1988;693-701.
14. Saverymuttu S.H., Crofton M.E., Peters A.M., Lavender J.P. Indium-111 tropolonate leukocyte scanning in the detection of intra-abdominal abscesses. Clin Radiol. 34:1983;593-596.
15. McCarthy K., Velchik M.G., Alavi A., Mandell G.A., Esterhai J.L., Goll S. In-111-labelled white blood cells in the detection of osteomyelitis complicated by a pre-existing condition. J Nucl Med. 29:1988;1015-1021.
16. Pring D.J., Henderson R.G., Keshavarzian A., et al. Indium granulocyte scanning in painful prosthetic joint. Radiology. 179:1991;645-647.
17. Palestro C.J., Kim D.K., Swyer A.J., Vallabhajosula S., Goldsmith S. Radionuclide diagnosis of vertebral osteomyelitis: In-111-leukocyte and Tc-99m methylene diphosphonate bone scintigraphy. J Nucl Med. 32:1991;1861-1865.
18. Becker W., Düsel W., Berger P., Spiegel W. The In-111-granulocyte scan in prosthetic vascular graft infections: imaging technique and results. Eur J Nucl Med. 13:1987;225-229.
19. Becker W., Borst U., Maisch B., Epping J., Börner W., Kochsiek K. In-111-labelled granulocytes in inflammatory heart diseases. Eur Heart. 8:(suppl J):1987;307-310.
20. Borst U., Becker W., Maisch B., Börner W., Kochsiek K. Clinical and prognostic effect of a positve granulocyte scan in infective endocarditis. Clin Nucl Med. 18:1993;35-39.
21. Van Royen A., Rövekamp M.H., van Dongen R.J.A.M., van de Schoot J.B., Hardeman R.M. In-111-leukocyte scintigraphy in the diagnosis of vascular graft infection. Hardeman M.R., Najean Y. Blood cells in nuclear medicine. Part I. Cell kinetics and biodistribution. 1984;341-347 Martinus Nijhoff, The Hague.
22. Becker W., Götz R., Heidbreder W., Börner W. Indium-111 white blood cell scan in the diagnosis of infectious complications in patients undergoing regular dialysis treatment. Bischof-Delaloye A., Blaufox M.D. Radionuclides in nephrology. 1986;191-195 Karger, Basel.
23. Cook P.S., Datz E.L., Disbro M.A., Alazraki N.P., Taylor A.T. Pulmonary uptake in In-111-leukocyte imaging: clinical significance in patients with suspected occult infection. Radiology. 150:1984;557-561.
24. Saverymuttu S.H., Philips G., Peters A.M., Lavender J.P. Indium-111-analogues leukocyte scanning in lobar pneumonia and lung abscesses. Thorax. 40:1985;925-930.
25. MacSweeney J.E., Peters A.M., Lavender J.P. Indium labelled leukocyte scanning in pyrexia of unknown origin. Clin Radiol. 42:1990;414-417.
26. Hawker R.J., Hall C.E., Drole Z., Rhys-Evans P.H. Indium-leukocyte imaging in true pyrexia of unknown origin. Eur J Nucl Med. 10:1985;172-174.
27. Peters A.M. The utility of Tc-99m-HMPAO leucocytes for imaging infection. Semin Nucl Med. XXIV:1994;110-127.
28. Locher J.T., Seybold K., Andres R.Y., Schubiger P.A., Mach J.P., Buchegger F. Imaging of inflammatory and infectious lesions after injection of radioiodinated monoclonal antigranulocyte antibodies. Nucl Med Commun. 7:1986;659-670.
29. Joseph K., Höffken H., Dammann V. In-vivo-Markierung von Granulozyten mit Tc-99m-markierten monoklonalen Antikörpern: erste klinische Ergebnisse. Nuc Compact. 18:1987;223-226.
30. Becker W., Blair J., Behr T., et al. Detection of soft-tissue infections and osteomyelitis using a technetium-99m-labeled antigranulocyte monoclonal antibody fragment. J Nucl Med. 35:1994;1436-1443.
31. Becker W., Goldenberg D.M., Wolf F. The use of monoclonal antibodies and antibody fragments in the imaging of infectious lesions. Semin Nucl Med. XXIV:1994;1-13.
32. Becker W., Palestro C.J., Winship J., et al. Rapid imaging of infections with a monoclonal antibody fragment (Leukoscan). Clin Orth Rel Res. 329:1996;263-272.
33. Gratz S., Braun H.G., Behr T.M., et al. Photopenia in chronic vertebral osteomyelitis with technetium-99m antigranulocyte antibody (BW 250/183). J Nucl Med. 98:1997;211-216.
34. Becker W., Fleig W., Marienhagen J., Hahn E., Wolf F. Diagnostische Bedeutung der intestinalen Aktivität bei der Immunszintigraphie mit Tc-99m-NCA-95-Antikörpern. Nukl-Med. 229:1990;47-48.
35. Almers S., Granerus G., Franzen L., Strom M. Technetium-99m scintigraphy: more accurate assessment of ulcerative colitis with exametazime-labelled leukocytes than with antigranulocyte antibodies. Eur J Nucl Med. 23:1996;247-255.
36. Cordes M., Hepp W., Langer R., Pannhorst J., Hierholzer J., Felix R. Vascular graft infection: detection by I-123-labeled antigranulocyte antibody (anti-NCA-95) scintigraphy. Nuklearmedizin. 30:1991;173-177.
37. Munz D.L., Morguet A.J., Sandrock D., et al. Radioimmunoimaging of subacute infective endocarditis using a technetium-99m monoclonal granulocyte specific antibody. Eur J Nucl Med. 18:1991;977-980.
38. Prvulovich E.M., Miller R.F., Costa D.C., et al. Immunoscintigraphy with a Tc-99m-labelled antigranulocyte monoclonal antibody in patients with human immunodeficiency virus infection and AIDS. AIDS. 16:1995;838-845.
39. Oyen W.J.G., Claessens R.A.M.J., van der Meer J.M.W., Corstens F.M.H. Biodistribution and kinetics of radiolabeled proteins in rats with focal infection. J Nucl Med. 33:1992;651-656.
40. Tahara T., Ichiya Y., Kuwabara Y., et al. High [18F]-fluorodeoxyglucose uptake in abdominal abscesses: a PET study. J Comput Assist Tomogr. 13:1989;829-831.
41. Osman S., Danpure H.J. The use of 2-[18F]fluoro-2-deoxy-d-glucose as a potential in vitro agent for labelling human granulocytes for clinical studies by positron emission tomography. Int J Radiat Appl Instrum [Part B]. 19:1992;183-190.
42. Forstrom L.A., Mullan B.P., Hung J.C., Lowe V.J., Thorson L.M. 18F-FDG labelling of human leucocytes. Nucl Med Commun. 21:2000;691-694.
43. Lehmann K., Meller J., Behe M., Becker W. F-18-FDG Uptake in Granulozyten: Basis der F-18-FDG Szintigraphie. Nuklearmedizin. 40:2001;V168.
44. Shepherd P.R., Kahn B.B. Glucose transporters and insulin action: implications for insulin resistance and diabetes mellitus. N Engl J Med. 341:1999;248-257.
45. Gould G.W., Holman G.D. The glucose transporter family: structure, function and tisssue-specific expression. Biochem J. 295:1993;329-341.
46. Daneman D., Zinman B., Elliott E., Bilan P.J., Klip A. Insulin-stimulated glucose transport in circulating mononuclear cells from nondiabetic and IDDM subjects. Diabetes. 41:1992;227-234.
47. Shreve P. Focal fluorine-18-fluorodeoxyclucose accumulation in inflammatory pancreatic disease. Eur J Nucl Med. 25:1998;259-264.
48. Lewis P.J., Salama A. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. J Nucl Med. 35:1994;1647-1649.
49. Ichiya Y., Kuwabara Y., Sasaki Yoshida T., et al. FDG-PET in infectious lesions: detection and assessment of lesion activity. Ann Nucl Med. 10:1996;185-191.
50. Sugawara Y., Braun D.K., Kison P.V., Russo J.E., Zasadny K.R., Wahl R.L. Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission tomography: preliminary results. Eur J Nucl Med. 259:1998;1238-1243.
51. Bakheet S.M., Powe J. Fluorine-18-fluorodeoxyglucose uptake in rheumatoid arthritis-associated lung disease in a patient with thyroid cancer. J Nucl Med. 39:1998;234-236.
52. Meller J., Lehmann K., Altenvoerde G., Jauho A., Becker W. 18-FDG Uptake bei einer Patientin mit fibröser Thyreoiditis (Riedel-Thyreoiditis). Nuklearmedizin. 39:2000;N115.
53. Meller J., Altenvoerde G., Munzel U., et al. Fever of unknown origin - prospective comparison of 18 FDG imaging with a double head coincidence camera (DHCC) and Ga-67 citrate SPECT. Eur J Nucl Med. 27:2000;1617-1625.
54. Meller J., Lehmann K., Sahlmann C., et al. F-18-FDG bei der Abklärung postoperativer Fieberzustände. Nuklearmedizin. 40:2001;V167.
55. O'Doherty M.J., Barrington S.F., Campbell M., et al. PET scanning and the human immunodeficiency virus-positive patient. J Nucl Med. 38:1997;1575-1583.
56. Guhlmann A., Brecht Krauss D., Suger G., et al. Fluorine-18-FDG PET and technetium-99m antigranulocyte antibody scintigraphy in chronic osteomyelitis. J Nucl Med. 39:1998;2145-2152.
57. Zhuang H., Duarte P.S., Pourdehand M., Shnier D., Alavi A. Exclusion of chronic osteomyelitis with F-18 fluorodeoxyglucose positron emission tomographic imaging. Clin Nucl Med. 25:2000;281-284.
58. Kalicke T., Schmitz A., Risse J.H., et al. Fluorine-18 fluorodeoxyglucose PET in infectious bone diseases: results of histologically confirmed cases. Eur J Nucl Med. 27:2000;524-528.
59. Van de Wiele C., Vandenberghe S., de Bondt P., de Clercq D., D'Asseler Y., Dierckx R. Coincidence camera FDG imaging for the diagnosis of chronic orthopedic infections: a feasibility study. J Comput Assist Tomogr. 25:2001;184-189.
60. Meller J., Altenvoerde G., Munzel U., et al. Fever of unknown origin - prospective comparison of F-18-FDG images with a double head coincidence camera (DHCC) and Ga-67 citrate SPECT. Eur J Nucl Med. 27:2000;1617-1625.
61. Meller J, Köster G, Liersch T, et al. Chronic bacterial osteomyelitis - prospective comparison of F-18-FDG imaging with a double head coincidence camera (DHCC) and In-111-labelled autologous leukocytes. Eur J Nucl Med ( in press).
62. Gratz S., Behr T., Hermann A., et al. Intraindividual comparison of Tc-99m labelled anti-SSEA-1 antigranulocyte antibody and Tc-99m-HMPAO labelled white blood cells for imaging of infection. Eur J Nucl Med. 25:1998;386-393.
63. Britton K. , Soroa V. , Amaral H. , et al. Tc-99m-infecton preliminary ecaluation in over 500 patients through an IAEA coordinated research programme. Eur J Nucl Med. 25:1998;874.
64. Keelan E.T.M., Harrison A.A., Chapman P.T., Binns R.M., Peters A.M., Haskard D.O. Imaging vascular endothelial activation: an approach using radiolabeled monoclonal antibodies against the endothelial cell adhesion molecule E-selectin. J Nucl Med. 35:1994;276-281.
65. Signore A., Parman A., Pozilli P., Andreani D., Beverly P.C.L. Detection of activated lymphocytes in endocrine pancreas of BB/W rats by injection of I-123-interleukin-2: an early sign of type I diabetes. Lancet. 2:1987;537-541.
66. Van der Laken J., Boerman O.C., Oyen W.J.G., et al. Recombinant human interleukin-1: potential agent to image infectious foci. Eur J Nucl Med. 21:1994;790.
67. Corstens F.H.M., Van der Meer J.W.M. Nuclear medicine′s role in infection and inflammation. Lancet. 354:1999;765-776.
68. Dams E.T.M., Oyen W.J.G., Boerman O., et al. First clinical evaluation of Tc-99m-PEG liposomes for the detection of infection and inflammation. Eur J Nucl Med. 25:1998;897P.